A Study to Assess the Safety of Single Doses of GSK189075 in Subjects With Type 1 Diabetes Mellitus
Status:
Completed
Trial end date:
2008-12-18
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to look at concentrations of GSK189075 in blood when
single doses of the drug are taken by mouth in combination with basal insulin. The clinical
effects of the drug in combination with insulin on the body will also be studied. The results
will help determine doses of GSK189075 can be studied in the future in the type I diabetes
mellitus population.